Extended endometrial ablation risks in the fertility sparing management of adenocarcinoma and atypical hyperplasia of the endometrium

被引：1
|
作者：
Gonthier, C. [1 ,2 ]
Luton, D. [1 ,2 ]
Koskas, M. [1 ,2 ]
机构：
[1] Hop Bichat Claude Bernard, AP HP, Serv Gynecol Obstet, F-75018 Paris, France
[2] Univ Paris 07, F-75018 Paris, France
来源：
GYNECOLOGIE OBSTETRIQUE & FERTILITE | 2015年 / 43卷 / 03期
关键词：
Endometrial cancer; Endometrial atypical hyperplasia; Fertility-sparing management; Hysteroscopic resection; Endometrial ablation; CANCER;
D O I：
10.1016/j.gyobfe.2015.01.009
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：185 / 186
页数：2
相关论文
共 50 条
  • [31] Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: Safety and Efficacy
    De Marzi, Patrizia
    Bergamini, Alice
    Luchini, Stefania
    Petrone, Micaela
    Taccagni, Gian Luca
    Mangili, Giorgia
    Colombo, Gabriella
    Candiani, Massimo
    [J]. JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY, 2015, 22 (07) : 1178 - 1182
  • [32] Quality of information and decision regrets during fertility-sparing management for atypical hyperplasia and endometrial cancer in a prospective cohort study
    Grenot, Marie
    Vandenbroucke, Tineke
    Bucau, Margot
    Koskas, Martin
    [J]. JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION, 2024, 53 (04)
  • [33] Impact of treatment duration in fertility-preserving management of endometrial cancer or atypical endometrial hyperplasia
    Wang, Yiqin
    Zhou, Rong
    Wang, Haibo
    Liu, Huixin
    Wang, Jianliu
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 (04) : 699 - 704
  • [34] THE RISK FACTORS AND THERAPEUTIC REGIMENS ANALYSES IN THE FERTILITY-SPARING TREATMENT OF REFRACTORY ENDOMETRIAL ATYPICAL HYPERPLASIA AND ENDOMETRIAL CANCER
    Yang, B.
    Zhou, S.
    Chen, X.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A381 - A381
  • [35] Atypical endometrial hyperplasia: Grounds for possible misdiagnosis of endometrial adenocarcinoma
    Valenzuela, P
    Sanz, JM
    Keller, J
    [J]. GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2003, 56 (03) : 163 - 167
  • [36] Insulin resistance and overweight prolonged fertility-sparing treatment duration in endometrial atypical hyperplasia patients
    Yang, Bingyi
    Xie, Liying
    Zhang, Hongwei
    Zhu, Qin
    Du, Yan
    Luo, Xuezhen
    Chen, Xiaojun
    [J]. JOURNAL OF GYNECOLOGIC ONCOLOGY, 2018, 29 (03)
  • [37] Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin
    Simpson, Andrea N.
    Feigenberg, Tomer
    Clarke, Blaise A.
    Gien, Lilian T.
    Ismiil, Nadia
    Laframboise, Stephane
    Massey, Christine
    Ferguson, Sarah E.
    [J]. GYNECOLOGIC ONCOLOGY, 2014, 133 (02) : 229 - 233
  • [38] Cancer Incidence in Patients with Atypical Endometrial Hyperplasia Managed by Primary Hysterectomy or Fertility-sparing Treatment
    Gonthier, Clementine
    Piel, Bruno
    Touboul, Cyril
    Walker, Francine
    Cortez, Annie
    Luton, Dominique
    Darai, Emile
    Koskas, Martin
    [J]. ANTICANCER RESEARCH, 2015, 35 (12) : 6799 - 6804
  • [39] INSULIN RESISTANCE AFFECTS THE THERAPEUTIC EFFECT OF FERTILITY-SPARING TREATMENT IN PATIENTS WITH ENDOMETRIAL ATYPICAL HYPERPLASIA
    Yang, B.
    Chen, X.
    Luo, X.
    Cheng, Y.
    Shan, W.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1286 - 1286
  • [40] Criteria for resumption of assisted reproductive technology intervention after fertility-sparing treatment of atypical endometrial hyperplasia and endometrial cancer
    Huttler, Alexandra G.
    Kahn, Jenna L.
    Shah, Divya K.
    Ko, Emily M.
    [J]. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2021, 42 (02) : 393 - 394
12345